Aconwell Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.40 M
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 2.44%
- Profit Growth 1.74%
- Ebitda 14.75%
- Net Worth 44.14%
- Total Assets 10.74%
About Aconwell Pharma
Aconwell Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 July 2019 (Five years and seven months 6 days old ). Its registered office is in Ambala Cant, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Jitender Singh, Vashist Sandhu, and Rocky serve as directors at the Company.
Company Details
- Location
Ambala Cant, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290HR2019PTC081592
- Company No.
081592
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Aconwell Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vashist Sandhu  | Director | 12-Nov-2020 | Current |
| Jitender Singh | Director | 22-Jul-2019 | Current |
| Rocky | Director | 22-Jul-2019 | Current |
Financial Performance of Aconwell Pharma.
Aconwell Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.44% increase. The company also saw a slight improvement in profitability, with a 1.74% increase in profit. The company's net worth Soared by an impressive increase of 44.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aconwell Pharma?
In 2023, Aconwell Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vaxova Drugs Private LimitedVashist Sandhu is a mutual person
Deltis Pharma Private LimitedVashist Sandhu is a mutual person
Alenvision Pharma Private LimitedJitender Singh is a mutual person
Alencure Biotech Private LimitedJitender Singh is a mutual person
Alfavision Biotech Private LimitedVashist Sandhu is a mutual person
- Vaxova Life Sciences Private Limited
Vashist Sandhu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aconwell Pharma?
Unlock and access historical data on people associated with Aconwell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aconwell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aconwell Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
